Company / Capital Expenditures
MARAVAI LIFESCIENCES HOLDINGS, INC. Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$13.1M
FY2025
5-year range
$13.1M / $65.6M
FY2021-FY2025
Trend
-55.7%
vs FY2024
Sector context
#54 of 194
Health Care
What the data says
At $13M, MARAVAI LIFESCIENCES HOLDINGS, INC.'s capital expenditures ranks #54 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 7 years, ranging from $13M in FY2025 to $66M in FY2023.
Based on SEC 10-K filings.
$13M in FY2025 with a 5-year CAGR of -12.3%.
Declined from $66M to $13M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -8.4%
- 5-Year CAGR
- -12.3%
- 10-Year CAGR
- -
Sector benchmark
#54 of 194 in Health CareTop 28% of 194This company $13.1M Sector average $117.5M
▼
-88.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -12.3%, indicating a declining trend.
- In FY2025, capital expenditures decreased 55.7% year-over-year.
- Ranks #54 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.1M | -55.7% |
| FY2024 | $29.7M | -54.8% |
| FY2023 | $65.6M | +283.6% |
| FY2022 | $17.1M | +15.1% |
| FY2021 | $14.8M | -41.6% |
| FY2020 | $25.4M | +48.2% |
| FY2019 | $17.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026